Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway

Yijiong Li(First Affiliated Hospital of Hebei Medical University), Xin Wang(Shanghai Medical College of Fudan University)
Experimental and Therapeutic Medicine
December 27, 2017
Cited by 12


Related Papers